chrisvoncsefalvay/vaers-outcomes huggingface dataset:
extremely painful neck ache; hard to turn my neck; muscle ache; first thought it was muscle ache but think it might be lymph nodes; first thought it was muscle ache but think it might be lymph nodes; This is a spontaneous report from a contactable consumer (Patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Left Arm on 26Feb2021 11:00 AM (Batch/Lot Number: EL9269, lot unknown: False) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. if Covid prior vaccination: No, if Covid tested post vaccination: No, other medical history: none. Facility type Vaccine: Hospital. Concomitant medication(s) included rosuvastatin calcium (CRESTOR) taken for an unspecified indication, start and stop date were not reported; tocopherol (VITAMIN E [TOCOPHEROL]) taken for an unspecified indication, start and stop date were not reported; selenium taken for an unspecified indication, start and stop date were not reported. The patient previously took demerol and experienced known allergies: Demerol. Other medications in two weeks: Crestor, antibiotics, Vitamin E, Selenium. Historical Vaccine included BNT162B2 (Product: COVID 19, brand: Pfizer, lot number: EL3247, lot unknown: False) on 05Feb2021 11:00 AM, vaccine location: Left arm, dose number: 1 for covid-19 immunisation. The patient experienced extremely painful neck ache (non-serious) on 01Mar2021, hard to turn my neck (non-serious) on 01Mar2021, muscle ache (non-serious) on 01Mar2021, first thought it was muscle ache but think it might be lymph nodes ((non-serious) on 01Mar2021,.  Adverse event: On the 3rd day following the 2nd injection I developed extremely painful neck ache, making it hard to turn my neck. This has lasted 5 days and does not seem to relent, although it is less sore. I first thought it was muscle ache but think it might be lymph nodes. Adverse event start date: 01Mar2021, Adverse Event. If patient recovered: Recovering. if treatment ae: No. If other vaccine in four weeks: No. For all events, outcome was recovering.   No follow-up attempts are possible. No further information is expected.
MILD FEVER; This spontaneous report received from a consumer concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, batch number: unknown, and expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. On an unspecified date, the patient experienced fever (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, batch number: unknown, and expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced mild fever (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild fever was not reported. This report was non-serious. This case, involving the same patient is linked to 20220624917.
no additional AE reported; MMR II was improperly stored and administered; This spontaneous report has been received from a nurse practitioner (also reported as nurse prescriber) referring to a patient of unknown age and unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported.  On 26-JUL-2021, the patient was vaccinated with an improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-R II) for prophylaxis (lot # T006166, expiration date 19-FEB-2022; strength, dose, and route were not reported). The product was stored at 55 Fahrenheit (F) from 08-JUN-2021 to 03-AUG-2021, the reporter was unable to provide total time out of range (product storage error). There was no previous temperature excursion. No additional adverse event was reported.
Pain at the vaccination site (left shoulder). Has been in constant pain immediately after Tdap vaccine on 02/18/2016, it has been 4 weeks and the pain is still there.
Pain in arm, around elbow, lasting 2 days.  Bad enough to keep awake.  Followed by swelling and heat in the lower arm, from the wrist to the elbow.
Left upper arm swollen, red and itchy. Keflex 250mg TIDX 10 days, alternate warm and cold compresses and Benadryl PRN.
1) within 10 minutes of injection - face above nose became tingly and tight - similar to a botox injection - this persisted for the rest of the day 2) Within 10 minutes of injection - dizziness (mild, could still drive) 3) Sore arm at injection site on Day 1 - mild, no redness or swelling 4) Within 1 hour of injection two toes of my left foot became too painful to walk on, but did not hurt when off my feet - lasted until evening, then gone 5)Within 1 hour of injection left leg had muscle aches and cramping 6) Within a few hours had a strange taste in my mouth (like a chemical)  - same with smell.  Lasted until bedtime - gone next day.  Day 2  Mild sore arm at injection site, but remainder of arm 'tingly' Left foot tingly (but toes not hurting) Nose goes completely numb - just the nose. Headache began - mild - alleviated, but not eliminated, with 800 mg IBuprofen Moderate Nausea began with gagging (but not vomiting) Moderate lower back pain  - could not move without ibuprofen - ended by nighttime and did not return Dark Urine - cleary dehydrating Dizziness became vertigo by noon second day.  Day 3)  Arm nearly normal Muscle aches gone Diarrhea began by 10 am Nausea returned - moderate, gagging no vomiting Headache worsened with extreme vertigo by noon Face tightens again - like wearing a tight scuba mask. First temperature - 101.0 800mg Ibuprofen helped overall feeling of illness, but headache not fully eliminated (better but not gone) Sleeping going fine.  Day 4  Fine upon waking - no pains Headache and Vertigo return by 10 am, both debilitating Moderate Nausea returns Diarrhea returns Fever less - 100.0 Overall feels like a very bad migraine with nausea and GI trouble, slight fever, and face muscles still intermittently 'tight'.
One week after my second Moderna shot pre-existing cysts in my left breast hardened and swell up with acute pain.  After an ultrasound confirming something had caused the cyst to react, inflaming the surrounding tissue they  aspirated it.  It wasn?t just the one cyst that had a reaction, it was across my entire left breast and part way through my right.  Lymph nodes were not swollen.
Seriousness criteria other medically significant (OMIC). Initial report received on 4/26/2006 from the patient. A 74 year old female patient, who had concurrent sinusitis, and was taking Ceftin, received an administration of a Diphtheria and tetanus toxoids, on 1/26/2006. The manufacturer, route, and site of administration were not reported. Two days post immunization, the patient had redness, and her arm was stiff and painful. She had mild fever of 100 deg F. Upon examination by a physician, the patient was treated with Epipen and prednisone. The next day, the redness was spreading and she went to the emergency room, where her temp was found to be 102 degree F, Benadryl was administered. The next day, the redness had spread to her elbow, and the injection site was hot and swollen. She returned to the ER where she was given Bactrim. A day later, the redness had spread under the arm, and the patient was sent to an infectious disease physician, who treated her with IV Solumedrol. She received two more doses of Iv Solumedrol over the next two days. After the last dose of IV Solumedrol on 2/2/2006 her symptoms resolved.
Fever: 102.2 F, Chills, Fatigue, Nausea, Vomiting, Headache, Body aches, Sore arm, Sore throat.
After vaccination administration (approximately 5 min), pt c/o lightheadedness, slumped in chair and fell over - breathing with pulse though unresponsive for approximately 3 min transported to hospital due to continued symptoms.
Got the shot on 1/5/2021 around noon. In about 2 hours, started feeling soreness around the injection area. After 14 hours of the shot, started feeling  chill, whole body joint and muscle pain, headache, fatigue, 99.5 fever. on 1/6, took Tylenol every 6 hours, three times in total, 1950 mg total dose. helped. felt a lot better on 1/7, the second day after the shot but still took 2 tablets of Tylenol before went to bed. on 1/8, felt totally fine.
Patient was unknowingly given Dose #3 of expired vaccine.  Patient was notified by the provider once it was realized
This spontaneous report as received from a pharmacy technician refers to a 1 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 9-MAR-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
Information has been received from a nurse practitioner (N.P.) concerning a 77 year old female patient with no pertinent medical history and allergy to Penicillin, Sulfa and Tetracycline who on 20-SEP-2010 was vaccinated with PNEUMOVAX 23. Concomitant therapy included KEFLEX. On 20-SEP-2010 evening, the patient developed cellulitis. The patient called the office and sought the medical attention. It improved after treatment with Prednisone. At the time of reporting, the patient was recovering. Cellulitis was considered to be disabling and an other important medical event by the reporter. Follow-up information was received from the nurse practitioner concerning the 77 year old female who on 20-SEP-2010 was vaccinated with a dose of PNEUMOVAX 23 (lot # 665924/0930Z) into her right deltoid. Subsequently, the patient experienced right arm extensive erythema, edema and pain. On 27-SEP-2010, the patient recovered. The cellulitis was considered to be other important medical events. No further information is available.
the first 3 days sore muscle near shoulder when lifting it up, warm at injection site , swollen at injection site.  third day back hurts and a little fatigued.
Adhesive capsulitis in upper right arm; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the right arm on 09Mar2021 as single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did receive any other medications within 2 weeks of vaccination. The patient had a history of allergy to clindamycin and Crestor. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 11Mar2021, the patient had experienced adhesive capsulitis in upper right arm. The patient did not receive treatment for the reported events. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of event adhesive capsulitis was not resolved at the time of report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Covid-19; diarrhea; nausea/vomiting; nausea/vomiting; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever). At the time of the report, COVID-19 (Covid-19), DIARRHOEA (diarrhea), NAUSEA (nausea/vomiting), VOMITING (nausea/vomiting) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Within 24-30 hours had asthma; skin infection; fatigue; extreme headache; eyes hurt went to eye doctor developed whole in left eye; pcp treated asthma and skin rash. Eye surgeon operated on left eye to verify it healed on it's own.
GOT A  CLOT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: unknown, expiry: unknown) dose, one total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, After two week post vaccination, the patient experienced got a clot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got a clot was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220406137-covid-19 vaccine ad26.cov2.s-got a clot. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
severe panic attacks; Neither him or I have been able to sleep for days.; This is a spontaneous report from a contactable consumer (patient). This is one of the 2 report from same reporter. A patient of an unknown age and gender received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) via an unknown route of administration on 06Apr2021 as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Approximately on an unknown date in Apr2021, the patient reported neither reporter's son nor reporter have been able to sleep for days. They have seen a doctor twice. Reporter stated that they ended up calling (emergency number) twice and other two times to urgent care with severe panic attacks. The reporter has been trying to find psychological therapy without any luck and that was not a normal reaction, reported as please help them. The outcome of events was unknown.  Information on Lot/Batch number has been requested.
Headache, fever, general weakness, frequent urination, diarrhea and right arm muscle pain.
Fever, severe headache, aches, nausea for 2 days symptomatic treatment at home - mom requested VAERS report be filed as this did not occur with previous 2 vaccines.
Took H1N1 last year, had itching all over the body immediately. Has an intradermal test of the flu vaccine this year - had a local redness and wheal > 2 cm in 1/2 an hour.
This spontaneous report was received from a medical assistant referring to multiple patients of unknown demographics. The pertinent medical history, concurrent conditions and concomitant therapies of the patients were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot# M034187, expiration date: 17-MAY-2019) (dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine underwent the temperature excursion of more than 32 Fahrenheit degrees (F) but less than 35 F for 3 hours and 20 minutes, which was detected by a data logger. No previous temperature excursions were reported. No adverse effects were reported. No Product Quality Complaint (PQC) was filed. This is one of two reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA006513.
develop back pain; unable to stand-up; pain with a diagnostic of possible muscle strain but nothing official as a diagnostic itself; pain with a diagnostic of possible muscle strain but nothing official as a diagnostic itself; still unable to bend or sit low without pain or help support; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 14Apr2021 11:00 (Batch/Lot number: unknown) at the age of 16 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Autism" (unspecified if ongoing). There were no concomitant medications. The following information was reported: BACK PAIN (non-serious) with onset 19Apr2021 08:00, outcome "recovering", described as "develop back pain"; DYSSTASIA (non-serious) with onset 19Apr2021 08:00, outcome "recovering", described as "unable to stand-up"; MYALGIA (non-serious), MUSCLE STRAIN (non-serious) all with onset 19Apr2021 08:00, outcome "recovering" and all described as "pain with a diagnostic of possible muscle strain but nothing official as a diagnostic itself"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 19Apr2021 08:00, outcome "recovering", described as "still unable to bend or sit low without pain or help support". The events "develop back pain", "unable to stand-up", "pain with a diagnostic of possible muscle strain but nothing official as a diagnostic itself", "pain with a diagnostic of possible muscle strain but nothing official as a diagnostic itself" and "still unable to bend or sit low without pain or help support" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of back pain. Therapeutic measures were not taken as a result of dysstasia, myalgia, muscle strain, joint range of motion decreased.  Additional information: The patient had no known allergies. The patient had received no other vaccines within 4 weeks prior to COVID vaccine. The patient had received no other medications within 2 weeks of vaccination. The patient had not diagnosed with COVID prior vaccination and had not tested to COVID post vaccination. Facility type vaccine was school or Health Clinic. After the shot the patient started to develop back pain to the point that as days go by he started hunch walking it was probably around 5 days of this symptoms until he was pretty much unable to stand-up walk that we had to take him to the ER then they ran a bunch of test as x-rays, blood test urine test etc, they all came out negative. He was send home to rest and Tylenol for pain with a diagnostic of possible muscle strain but nothing official as a diagnostic itself. It's been a week and the patient still unable to bend or sit low without pain or help support. It's important to address these symptoms because there was no data of side effects for kids with autism.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Stated had bad reaction to flu shot rcvd Monday 10/26/09: reports mild fever, chills, nausea and achiness all day Tuesday, better Wednesday and today. Reports no cough except first thing in am. Myalgia. Fever. Nausea Vomiting.
This literature report concerns a 51-year-old female patient. Her past medical history was significant for HIV (human immunodeficiency virus) with a CD4 count of 656. Her medications at home included atorvastatin 10 mg a day, efavirenz-emtricitabine-tenofovir 600-200-300 mg once a day. On an unknown date the patient received influenza vaccination (manufacturer unknown). The patient presented to the ER (Emergency Room) with the complaints of generalized weakness and non-productive cough. Her symptoms started about three weeks ago when she received Influenza vaccination. After that injection, she started experiencing flu-like symptoms. Her weakness started in all extremities at the same time. She did report mild shortness of breath and a nonproductive cough as well. She took acetaminophen over the counter but unfortunately did not get better. On the day of admission she had been nauseated and had one episode of emesis in the ER. Review of systems was normal except for above. Upon admission, the patient's temperature was 35.2 degrees C; she was tachycardic at 103 beats per minute, blood pressure of 130/56 mmHg, respiratory rate of 18 breaths per minute with oxygen saturation of 100% on room air. Her physical examination was unremarkable. Laboratory workup revealed a normal complete blood count. Metabolic panel showed hyperchloremic metabolic acidosis with a sodium of 143 meq/L, potassium of 3.7 meq/L, chloride of 122 meq/L, bicarbonate of 11.3 meq/L, anion gap of 9.7 meq/L, blood urea nitrogen of 29 mg/100 ml, creatinine of 1.5 mg/100 ml, GFR of 38.9 ml/minute, glucose of 133 mg, and a calcium of 9.1 mg/100 ml. Urinalysis did not show acetones and showed +1 blood, +2 proteinuria, +1 leukocyte esterase. Lactic acid level was 0.3 mmol/L. ABG showed a PH of 7.21, carbon dioxide level of 19.8 mmHg. Urine electrolytes showed sodium of 85 meq/l, potassium level of 24 meq/l, and a chloride of 90 meq/l. Tenofovir was discontinued. The patient was treated with a solution of dextrose 5% plus sodium bicarbonate started at a rate of 18.75 meq/hr, multiple doses of sodium phosphate, potassium chloride, and calcium gluconate. Her condition gradually improved with eventual correction of acidosis and the acute renal failure. The patient was discharged on calcium carbonate 600 mg PO TID (three times daily). HIV clinic was notified about the need to change HAART (highly active anti-retroviral therapy) regimen. The event outcome was not reported.
Bad reaction; Patient was in bed for 24 hours after vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of NONSPECIFIC REACTION (Bad reaction) and BEDRIDDEN (Patient was in bed for 24 hours after vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NONSPECIFIC REACTION (Bad reaction) and BEDRIDDEN (Patient was in bed for 24 hours after vaccine). At the time of the report, NONSPECIFIC REACTION (Bad reaction) and BEDRIDDEN (Patient was in bed for 24 hours after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.